-
Register
- User - $30
Heart failure impacts the lifestyle of patients in a variety of ways. This talk will review the recommendations that the 2022 Guidelines for the Management of Heart Failure provide for self-care, diet, exercise, cardiac rehab, and mental health. Optimal care will be detailed while also discussing barriers that prevent optimal care. This presentation will highlight ways that primary care clinicians can support patients with heart failure and optimize patient quality of life.
Credits: 1.0 Contact Hours; 0.25 are Pharmacology
Expiration Date: December 31st, 2024
$30
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Discuss 2022 AHA/ACC/HFSA Guidelines for Management of Heart Failure.
-Highlight potential barriers to following healthy lifestyle interventions in patients with heart failure.
-Discuss 2022 ISHLT Guidelines for the Care of Heart Transplant Recipients.
Laura Peters, DNP, FNP-C
Family Nurse Practitioner, Assistant Professor
University of Colorado
Laura L. Peters is a board-certified Family Nurse Practitioner and an Assistant Professor of Medicine in the Advanced Heart Failure and Cardiac Transplant section within the Division of Cardiology in the Department of Medicine at the University of Colorado. Additionally, she is a Senior Clinical Instructor in the University of Colorado College of Nursing. She is also the Director of the Children’s Hospital Colorado and UCHealth Heart Transplant Transition Program.
She obtained her Bachelor of Science in Nursing degree from Calvin College in Grand Rapids, MI. She obtained her Master of Science in Nursing, Family Nurse Practitioner, as well as her Doctor of Nursing Practice, at the University of Colorado College of Nursing.
She is involved in several quality improvement projects throughout her healthcare organization, including integration of behavioral health care and advance care planning in chronic patient populations. She is passionate about the impact of mental health, healthy lifestyle habits, and advance care planning in patients with chronic disease states.
She is an active member of many professional societies including the Heart Failure Society of America where she currently serves on the HFSA Certification Program Committee, Annual Scientific Meeting, and previous Chair of the Nursing Committee.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.0 contact hours, of which 0.25 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Laura Peters, DNP, FNP-C have disclosed have disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
